Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
Clinical trial NCT05048368 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05048368
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-30
- Primary completion
- 2026-12-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.